Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

EMISEmmis Acquisition Corp.

Nasdaq · CIK 0002075816
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts63

Identity from submissions API

NameEmmis Acquisition Corp.
CIK0002075816
TickersEMIS, EMISR
ExchangesNasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone954-294-6285
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
515 E LAS OLAS BLVD
SUITE 120
FORT LAUDERDALE
FL
33301
FL
Mailing address
515 E LAS OLAS BLVD
SUITE 120
FORT LAUDERDALE
FL
33301
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

49 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q QUARTERLY REPORT 0001213900-26-120611 001-42861 261560523 34 3792685 1 1
2026-09-28 4 xslF345X06/ownership.xml 0001213900-26-104167 6214
2026-09-28 8-K CURRENT REPORT 5.02,9.01 0001213900-26-104036 001-42861 261417271 34 262357 1 1
2026-09-28 4 xslF345X06/ownership.xml 0001213900-26-104037 5251
2026-09-28 3 xslF345X06/ownership.xml 0001213900-26-104033 3095
2026-08-06 10-Q QUARTERLY REPORT 0001213900-26-086134 001-42861 261248911 34 3550251 1 1
2026-05-14 10-Q QUARTERLY REPORT 0001213900-26-056665 001-42861 26979390 34 3296163 1 1
2026-03-27 10-K ANNUAL REPORT 0001213900-26-035521 001-42861 26807559 34 4795305 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-051885 005-95245 26635085 34 34871
2026-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001072613-26-000161 005-95245 26632791 34 7601
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000927971-26-000012 005-95245 26623317 34 190080
2026-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001167557-26-000008 005-95245 26619103 34 10277
2025-11-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001076809-25-000125 005-95245 251479208 34 9112
2025-11-13 10-Q QUARTERLY REPORT 0001213900-25-110007 001-42861 251478788 34 3096361 1 1
2025-11-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000927971-25-000034 005-95245 251475957 34 190360
2025-11-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001167557-25-000045 005-95245 251475740 34 10180
2025-11-12 3 xslF345X02/ownership.xml 0001213900-25-108821 3381
2025-11-04 10-Q QUARTERLY REPORT 0001213900-25-106172 001-42861 251449806 34 2450019 1 1
2025-10-21 25-NSE xslF25X02/primary_doc.xml 0001354457-25-001046 333-288530 251407254 34 3003
2025-10-16 8-K CURRENT REPORT 8.01,9.01 0001213900-25-099249 001-42861 251395940 34 276386 1 1
2025-10-07 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-096868 005-95245 251378669 34 27771
2025-10-02 8-K CURRENT REPORT 8.01,9.01 0001213900-25-095324 001-42861 251368466 34 395340 1 1
2025-10-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-226853 005-95245 251365119 34 23784
2025-10-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-226051 005-95245 251362844 34 34600
2025-09-30 4 OWNERSHIP DOCUMENT 0001213900-25-093530 10193
2025-09-29 8-K CURRENT REPORT 1.01,3.02,5.02,5.03,8.01,9.01 0001213900-25-093113 001-42861 251356526 34 2251344 1 1
2025-09-26 424B4 PROSPECTUS 0001213900-25-091808 333-288530 251345088 33 2145965
2025-09-25 3 xslF345X02/ownership.xml 0001213900-25-091747 3184
2025-09-25 3 xslF345X02/ownership.xml 0001213900-25-091472 5925
2025-09-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003075 333-288530 251340134 33 1766
2025-09-24 3 xslF345X02/ownership.xml 0001213900-25-091279 5791
2025-09-24 CERT EMIS_8A_Cert_2075816.pdf 0001354457-25-000942 001-42861 251339124 34 121646
2025-09-24 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-25-090873 001-42861 251335209 34 16601
2025-09-23 CORRESP filename1.htm 0001213900-25-090728 6362
2025-09-23 CORRESP filename1.htm 0001213900-25-090726 8045
2025-09-22 CORRESP filename1.htm 0001213900-25-090178 10736
2025-09-22 S-1/A AMENDMENT NO. 5 TO FORM S-1 0001213900-25-090176 333-288530 251330848 33 644313 1 1
2025-09-18 UPLOAD filename1.pdf 0000000000-25-010188 333-288530 43362
2025-09-17 CORRESP filename1.htm 0001213900-25-088350 14376
2025-09-17 S-1/A AMENDMENT NO. 4 TO FORM S-1 0001213900-25-088349 333-288530 251318763 33 643966 1 1
2025-09-16 UPLOAD filename1.pdf 0000000000-25-010022 333-288530 45511
2025-09-12 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-25-087025 333-288530 251309973 33 38619548 1 1
2025-08-29 CORRESP filename1.htm 0001213900-25-082556 28955
2025-08-29 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-25-082545 333-288530 251280626 33 4252060 1 1
2025-08-27 UPLOAD filename1.pdf 0000000000-25-009169 333-288530 46395
2025-08-13 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-075824 333-288530 251213010 33 4130244 1 1
2025-08-13 CORRESP filename1.htm 0001213900-25-075826 31839
2025-07-31 UPLOAD filename1.pdf 0000000000-25-008058 333-288530 56570
2025-07-03 S-1 REGISTRATION STATEMENT 0001213900-25-061576 333-288530 251106454 33 4136275 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (63 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-27 0001213900-26-035521
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 83,163 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 2,333 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035521
us-gaap AccruedLiabilitiesFairValueDisclosure Accrued Liabilities, Fair Value Disclosure USD 62,333 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 233,554 2025-12-31 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 2.07M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs USD -59,680 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap Assets Assets USD 119.99M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap AssetsCurrent Assets, Current USD 783,209 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 119.21M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap AssetsNoncurrent Assets, Noncurrent USD 119.21M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap Cash Cash USD 663,459 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 0 2025-06-30 2025 Q2 10-Q 2025-11-04 0001213900-25-106172
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 663,459 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -284,409 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 61,500 2025-06-30 2025 Q2 10-Q 2025-11-04 0001213900-25-106172
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 122,098 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110007
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.01 2025-03-21 2025-06-30 2025 Q2 10-Q 2025-11-04 0001213900-25-106172
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.01 2025-03-21 2025-06-30 2025 Q2 10-Q 2025-11-04 0001213900-25-106172
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 40,139 2025-03-21 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 61,456 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 77,621 2025-03-21 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110007
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -69,573 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap IncreaseDecreaseInPrepaidInsurance Increase (Decrease) in Prepaid Insurance USD -34,045 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 3.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap Liabilities Liabilities USD 158,163 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 119.99M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap LiabilitiesCurrent Liabilities, Current USD 158,163 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 152,114 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110007
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 10 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -115.00M 2025-03-21 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -284,419 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 3.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap NotesPayableCurrent Notes Payable, Current USD 34,280 2025-06-30 2025 Q2 10-Q 2025-11-04 0001213900-25-106172
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001213900-26-086134
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -449,493 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 19,100 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 357,340 2025-03-21 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 115.00M 2025-03-21 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035521
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 115.00M 2025-03-21 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 100,650 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 25,000 2025-03-21 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.67M 2025-03-21 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 113.28M 2025-03-21 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -152,113 2025-03-21 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap RepaymentsOfDebt Repayments of Debt USD 152,114 2025-03-21 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035521
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 152,113 2025-06-17 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 624,618 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 449,493 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 625,046 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 8 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 3.67M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 1.03M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-06-30 2025 Q2 10-Q 2025-11-04 0001213900-25-106172
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-06-30 2025 Q2 10-Q 2025-11-04 0001213900-25-106172
us-gaap UnsecuredDebt Unsecured Debt USD 300,000 2025-09-26 2026 Q3 10-Q 2026-11-16 0001213900-26-120611
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 3.33M 2025-03-21 2025-06-30 2025 Q2 10-Q 2025-11-04 0001213900-25-106172
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 3.33M 2025-03-21 2025-06-30 2025 Q2 10-Q 2025-11-04 0001213900-25-106172

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →